78. 下垂体前葉機能低下症 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 34 / 薬物数 : 44 - (DrugBank : 11) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 19
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Acipimox
University of Aarhus
2016 - NCT02782208 Denmark
2012 - NCT01209416 Denmark
Anastrozole
Nemours Children's Clinic
2001 Phase 2/Phase 3 NCT00133354 United States
- - EUCTR2012-001183-30-Outside-EU/EEA United States
Arimidex
Nemours Children's Clinic
2001 Phase 2/Phase 3 NCT00133354 United States
- - EUCTR2012-001183-30-Outside-EU/EEA United States
Byetta
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
2021 Phase 2 EUCTR2020-004115-27-ES Spain
Corticotropin
Max-Planck-Institute of Psychiatry
2008 - NCT00666068 Germany
CRH administration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2021 Phase 4 NCT04902235 Spain
Exenatide
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
2021 Phase 2 EUCTR2020-004115-27-ES Spain
Genotropin 12MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin 5.3MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick
Dr. Chris Thompson
2006 Phase 4 EUCTR2005-005613-38-IE Ireland
Genotropin miniquick 0.2MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.4MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.6MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.8MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 1.0MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 1.2MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
GH pause
University of Aarhus
2016 - NCT02782208 Denmark
GH substitution
University of Aarhus
2016 - NCT02782208 Denmark
Ghrelin
University of Aarhus
2012 - NCT01209416 Denmark
GLP1-RA (exenatide) administration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2021 Phase 4 NCT04897802 Spain
Growth hormone
Center for Neurological Studies
2019 Phase 2 NCT04121780 United States
Federico II University
1996 - NCT00462475 Italy
Nemours Children's Clinic
2001 Phase 2/Phase 3 NCT00133354 United States
Stanford University
2009 Phase 3 NCT01007071 United States
Human acylated ghrelin
University of Aarhus
2005 - NCT00139945 Denmark
Hydrocortisone
Amar Agha
2008 Phase 4 EUCTR2007-005018-37-IE Ireland
University Hospital Inselspital, Berne
2015 - NCT02360046 Switzerland
Hydrocortisone takeda, tabletter
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark
Hydrocortone
Amar Agha
2008 Phase 4 EUCTR2007-005018-37-IE Ireland
Bradford Teaching Hospitals NHS Foundation Trust
2004 Phase 4 EUCTR2004-002056-34-GB United Kingdom
Hydrokortison glostrup 5 MG
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark
Intravenous infusion OF diclofenac sodium
Azienda Ospedaliera Città della Salute e della Scienza di Torino
2021 Phase 4 NCT05188131 Italy
Levothyroxine
Christie Hospital NHS Trust
2005 - EUCTR2004-005184-15-GB United Kingdom
Rigshospitalet, Denmark
2012 - NCT01574859 Denmark
Melatonin
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2022 - NCT05319301 Spain
Nutropin AQ
Children's Hospital Los Angeles
2004 Phase 4 NCT00140413 United States
Oestrogen
University of Aarhus
2001 - NCT00572390 Denmark
Plenadren 20 MG modified-release tablets
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark
Plenadren 5 MG modified-release tablets
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark
Routine transdermal oestrogen patch
University College, London
2016 - NCT02871986 United Kingdom
Somatropin
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Eli Lilly and Company
2002 - NCT01088399 -
1999 Phase 4 NCT00490191 France;Germany;Italy;Puerto Rico;United Kingdom;United States
Novo Nordisk A/S
2002 - NCT01009905 United States
Synacthen
Cardiff University
2008 Phase 4 NCT00851942 United Kingdom
2008 Phase 4 EUCTR2007-000056-14-GB United Kingdom
Testogel
Dr. Chris Thompson
2006 Phase 4 EUCTR2005-005613-38-IE Ireland
Testosterone plus somatropin
University of Pennsylvania
2004 Phase 2 NCT00080483 United States
Tetracosactrin
Cardiff University
2008 Phase 4 NCT00851942 United Kingdom
Theraderm
Massachusetts General Hospital
2001 - NCT00027430 United States
Thyroxin, triiodothyronine
University Hospital Freiburg
2004 Phase 4 NCT00360074 Germany
Transdermal testosterone GEL
Charles Drew University of Medicine and Science
2003 Phase 4 NCT00144391 United States
Trisequens
Dr. Chris Thompson
2006 Phase 4 EUCTR2005-005613-38-IE Ireland
ZD1033
Nemours Children's Clinic
- - EUCTR2012-001183-30-Outside-EU/EEA United States
University of Aarhus
2016 - NCT02782208 Denmark
2012 - NCT01209416 Denmark
Anastrozole
Nemours Children's Clinic
2001 Phase 2/Phase 3 NCT00133354 United States
- - EUCTR2012-001183-30-Outside-EU/EEA United States
Arimidex
Nemours Children's Clinic
2001 Phase 2/Phase 3 NCT00133354 United States
- - EUCTR2012-001183-30-Outside-EU/EEA United States
Byetta
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
2021 Phase 2 EUCTR2020-004115-27-ES Spain
Corticotropin
Max-Planck-Institute of Psychiatry
2008 - NCT00666068 Germany
CRH administration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2021 Phase 4 NCT04902235 Spain
Exenatide
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
2021 Phase 2 EUCTR2020-004115-27-ES Spain
Genotropin 12MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin 5.3MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick
Dr. Chris Thompson
2006 Phase 4 EUCTR2005-005613-38-IE Ireland
Genotropin miniquick 0.2MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.4MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.6MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 0.8MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 1.0MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Genotropin miniquick 1.2MG
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
GH pause
University of Aarhus
2016 - NCT02782208 Denmark
GH substitution
University of Aarhus
2016 - NCT02782208 Denmark
Ghrelin
University of Aarhus
2012 - NCT01209416 Denmark
GLP1-RA (exenatide) administration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2021 Phase 4 NCT04897802 Spain
Growth hormone
Center for Neurological Studies
2019 Phase 2 NCT04121780 United States
Federico II University
1996 - NCT00462475 Italy
Nemours Children's Clinic
2001 Phase 2/Phase 3 NCT00133354 United States
Stanford University
2009 Phase 3 NCT01007071 United States
Human acylated ghrelin
University of Aarhus
2005 - NCT00139945 Denmark
Hydrocortisone
Amar Agha
2008 Phase 4 EUCTR2007-005018-37-IE Ireland
University Hospital Inselspital, Berne
2015 - NCT02360046 Switzerland
Hydrocortisone takeda, tabletter
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark
Hydrocortone
Amar Agha
2008 Phase 4 EUCTR2007-005018-37-IE Ireland
Bradford Teaching Hospitals NHS Foundation Trust
2004 Phase 4 EUCTR2004-002056-34-GB United Kingdom
Hydrokortison glostrup 5 MG
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark
Intravenous infusion OF diclofenac sodium
Azienda Ospedaliera Città della Salute e della Scienza di Torino
2021 Phase 4 NCT05188131 Italy
Levothyroxine
Christie Hospital NHS Trust
2005 - EUCTR2004-005184-15-GB United Kingdom
Rigshospitalet, Denmark
2012 - NCT01574859 Denmark
Melatonin
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2022 - NCT05319301 Spain
Nutropin AQ
Children's Hospital Los Angeles
2004 Phase 4 NCT00140413 United States
Oestrogen
University of Aarhus
2001 - NCT00572390 Denmark
Plenadren 20 MG modified-release tablets
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark
Plenadren 5 MG modified-release tablets
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark
Routine transdermal oestrogen patch
University College, London
2016 - NCT02871986 United Kingdom
Somatropin
Amar Agha, Beaumont Hospital
2009 Phase 4 EUCTR2009-010918-30-IE Ireland
Eli Lilly and Company
2002 - NCT01088399 -
1999 Phase 4 NCT00490191 France;Germany;Italy;Puerto Rico;United Kingdom;United States
Novo Nordisk A/S
2002 - NCT01009905 United States
Synacthen
Cardiff University
2008 Phase 4 NCT00851942 United Kingdom
2008 Phase 4 EUCTR2007-000056-14-GB United Kingdom
Testogel
Dr. Chris Thompson
2006 Phase 4 EUCTR2005-005613-38-IE Ireland
Testosterone plus somatropin
University of Pennsylvania
2004 Phase 2 NCT00080483 United States
Tetracosactrin
Cardiff University
2008 Phase 4 NCT00851942 United Kingdom
Theraderm
Massachusetts General Hospital
2001 - NCT00027430 United States
Thyroxin, triiodothyronine
University Hospital Freiburg
2004 Phase 4 NCT00360074 Germany
Transdermal testosterone GEL
Charles Drew University of Medicine and Science
2003 Phase 4 NCT00144391 United States
Trisequens
Dr. Chris Thompson
2006 Phase 4 EUCTR2005-005613-38-IE Ireland
ZD1033
Nemours Children's Clinic
- - EUCTR2012-001183-30-Outside-EU/EEA United States